Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer.

Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer.
复制标题

DOI:
10.1038/bjc.2013.350
复制
发表时间:
2013-07-23
影响因子:
8.8
通讯作者:
Kubota K
Kubota K
中科院分区:
医学1区
文献类型:
--
作者:
Ishizuka M;Nagata H;Takagi K;Iwasaki Y;Kubota K

文献摘要

参考文献

被引文献

相似文献

本研究探讨了一种新的基于炎症的预后系统,名为COP-NLR(血小板计数和中性粒细胞与淋巴细胞比率的组合),用于预测结直肠癌(CRC)患者的术后生存率。COP-NLR是根据入院当天获得的数据计算的:血小板计数升高(>30 × 104 mm−3)和NLR升高(>3)的患者被分配为2分,而显示一个或两个都没有的患者分别被分配为1分或0分。480例患者入组。单因素分析选择的临床特征的多因素分析显示,COP-NLR(1,2/0)(比值比,0.464; 95%可信区间,0.267-0.807; P=0.007)与肿瘤特异性生存率相关,沿着病理、淋巴结转移、血清癌胚抗原、C反应蛋白和白蛋白水平,和格拉斯哥预后评分。Kaplan-Meier分析和log-rank检验显示COP-NLR能够将此类患者分为3个独立组(P<0.001)。COP-NLR被认为是CRC患者术后生存的有用预测因子。
This study investigated the usefulness of a novel inflammation-based prognostic system, named the COP-NLR (COmbination of Platelet count and Neutrophil to Lymphocyte Ratio), for predicting the postoperative survival of patients with colorectal cancer (CRC). The COP-NLR was calculated on the basis of data obtained on the day of admission: patients with both an elevated platelet count (>30 × 104 mm−3) and an elevated NLR (>3) were allocated a score of 2, and patients showing one or neither were allocated a score of 1 or 0, respectively. Four-hundred and eighty patients were enrolled. Multivariate analysis of clinical characteristics selected by univariate analysis showed that the COP-NLR (1, 2/0) (odds ratio, 0.464; 95% confidence interval, 0.267–0.807; P=0.007) had an association with cancer-specific survival, along with pathology, lymph node metastasis, the serum levels of carcinoembryonic antigen, C-reactive protein and albumin, and the Glasgow Prognostic Score. Kaplan–Meier analysis and log-rank test revealed that the COP-NLR was able to divide such patients into three independent groups (P<0.001). The COP-NLR is considered to be a useful predictor of postoperative survival in patients with CRC.
DOI: 10.1073/pnas.94.2.663
发表时间: 1997-01-21
影响因子: 11.1
作者:
Mohle, R;Green, D;Rafii, S
通讯作者: Rafii, S
DOI: 10.1097/sla.0b013e3181454171
发表时间: 2007-12-01
期刊: ANNALS OF SURGERY
影响因子: 9
作者:
Ishizuka, Mitsuru;Nagata, Hitoshi;Kubota, Keiichi
通讯作者: Kubota, Keiichi
DOI: 10.1016/j.ejso.2010.05.004
发表时间: 2010-07-01
期刊: EJSO
影响因子: 3.8
作者:
Kim, H. S.;Han, K. H.;Kang, S. B.
通讯作者: Kang, S. B.
DOI: 10.1111/igc.0b013e3181a47d47
发表时间: 2009-11-01
影响因子: 4.8
作者:
Gorelick, Constantine;Andikyan, Vaagn;Abulafia, Ovadia
通讯作者: Abulafia, Ovadia
DOI: 10.1002/eji.1830180817
发表时间: 1988-08-01
影响因子: 5.4
作者:
RAMADORI, G;VANDAMME, J;BUSCHENFELDE, KHMZ
通讯作者: BUSCHENFELDE, KHMZ